Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors

FEBS Letters
J Budworth, A Gescher

Abstract

The hypothesis was tested that 9 kinase inhibitors with diverse specificities for protein kinase C (PKC), including staurosporine and four of its analogues, interfere differently with PKC derived from either the cytosolic or particulate fractions of MCF-7 breast carcinoma cells. GF 109203X inhibited the enzyme identically in either preparation. CGP 41251 and calphostin C inhibited cytosolic PKC more effectively than membrane-derived PKC with ratios of IC50 (cytosolic PKC) over IC50 (membrane-derived PKC) of 0.07 and 0.04, respectively. The other six agents inhibited membrane-derived PKC more potently than cytosolic enzyme. Staurosporine and RO 31 8220 exhibited IC50 ratios of 12.3 and 21.6, respectively. The results suggest that there are dramatic differences between kinase inhibitors in their divergent effects on cytosolic and membrane-derived PKC which should be borne in mind in the interpretation of their pharmacological properties.

References

Aug 1, 1990·Bio/technology·T Tamaoki, H Nakano
May 1, 1992·Biochemical Society Transactions·J S NixonM Mulqueen
Mar 1, 1992·Molecular and Cellular Biology·H GreifE Livneh
Apr 15, 1991·Biochemical and Biophysical Research Communications·R F BrunsH Nakano
Mar 15, 1989·Biochemical and Biophysical Research Communications·E KobayashiT Tamaoki
Dec 1, 1987·The Journal of Antibiotics·I TakahashiH Nakano
Mar 13, 1986·Biochemical and Biophysical Research Communications·T TamaokiF Tomita
Feb 15, 1994·International Journal of Cancer. Journal International Du Cancer·C StanwellG R Pettit

❮ Previous
Next ❯

Citations

Jul 2, 1998·Journal of Cellular Physiology·S C HeffelfingerG Devoe
Sep 27, 2000·International Journal of Cancer. Journal International Du Cancer·H U KellerJ Sroka
Feb 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J L SolanR A Terkeltaub
Sep 5, 1996·European Journal of Pharmacology·K LoneraganP D Marley
Oct 8, 1998·Reproductive Toxicology·K W WardE S Hunter
May 9, 2000·Critical Reviews in Oncology/hematology·A Gescher
Apr 1, 1996·British Journal of Pharmacology·L M ShubaT F McDonald
Jan 5, 2002·Expert Opinion on Investigational Drugs·P G Goekjian, M R Jirousek
Nov 4, 2008·Journal of Molecular and Cellular Cardiology·Kylie VenardosDavid M Kaye
Oct 23, 1997·The Journal of Physiology·J P O'ReillyG G Haddad
Jun 20, 2015·Journal of Immunology Research·Rouba Hage-SleimanGhassan Dbaibo
Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D MechtcheriakovaE Hofer
Oct 12, 1999·The American Journal of Physiology·T HayashiL J Goodyear
Mar 11, 2000·American Journal of Physiology. Cell Physiology·M KurosawaT Yoshida
Dec 22, 1999·The American Journal of Physiology·P SilvaF H Epstein
Mar 6, 2021·Natural Product Reports·George E ChambersRichard C D Brown
Dec 31, 1997·The American Journal of Physiology·Q Huang, Y Yuan
Nov 11, 1998·General Pharmacology·A Gescher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.